{"id":128428,"date":"2023-11-28T19:23:25","date_gmt":"2023-11-28T19:23:25","guid":{"rendered":"https:\/\/learnexams.com\/blog\/?p=128428"},"modified":"2023-11-28T19:23:27","modified_gmt":"2023-11-28T19:23:27","slug":"ons-oncc-chemotherapy-biotherapy-certification-exam-2023-2024-update-questions-and-verified-answers100-correct-grade-a-2","status":"publish","type":"post","link":"https:\/\/www.learnexams.com\/blog\/2023\/11\/28\/ons-oncc-chemotherapy-biotherapy-certification-exam-2023-2024-update-questions-and-verified-answers100-correct-grade-a-2\/","title":{"rendered":"ONS\/ONCC Chemotherapy Biotherapy Certification Exam (2023\/ 2024 Update) Questions and Verified Answers|100% Correct- Grade A"},"content":{"rendered":"\n

ONS\/ONCC Chemotherapy Biotherapy Certification Exam (2023\/ 2024 Update) Questions and Verified Answers|100% Correct- Grade A<\/p>\n\n\n\n

ONS\/ONCC Chemotherapy Biotherapy
Certification Exam (2023\/ 2024 Update)
Questions and Verified Answers|100%
Correct- Grade A
Q: True or False: When administering an IV push medication the nurse should open the clamp
of compatible intravenous solution until increased flow is seen to dilute the agent during
administration
Answer:
True
Q: During the 2 RN check, the correct patient and dose is to be verified at the —
Answer:
bedside\/chairside
Q: Continuous infusion of vesicants must be through a —
Answer:
Central Line
Q: Family and — of the patient need taught about excretion safety precautions
Answer:
friends<\/p>\n\n\n\n

Q: Excretion safety precautions last for — to — days
Answer:
3, 7
Q: True or False: When evaluating a patient prior to chemotherapy, the nurse notes the patient
recently had weight loss. The nurse recalculates the dose and discovers the change in the dose is
greater than 5%. The next step for the nurse is to notify the attending physician that the patient
will need re-consented because of the dose adjustment
Answer:
False
Q: Alkylating agents are cell cycle specific. They work on — and resting cells
Answer:
dividing
Q: Alkylating agents are effective in slow growing tumors and large tumors that have few
actively — cells
Answer:
dividing
Q: List three toxicities common in all alkylating agents:
Answer:<\/p>\n\n\n\n

    \n
  1. Nausea<\/li>\n\n\n\n
  2. Vomiting<\/li>\n\n\n\n
  3. Myelosuppression<\/li>\n\n\n\n
  4. Infertility<\/li>\n\n\n\n
  5. Alopecia<\/li>\n\n\n\n
  6. Tumor Lysis Syndrome (TLS)
    Q: Which class of drugs can cross the blood brain barrier, increasing a patient’s risk for CNS
    toxicities?
    Answer:
    Nitrosureas
    Q: — is the solvent of carmustine (BCNU)
    Answer:
    Sterile Alcohol
    Q: The — formula ia used to calculate Carboplatin dosage
    Answer:
    Calvert
    Q: True or False: Temozolamide (Temodar) effectively crosses the blood brain barrier
    Answer:
    True
    Q: Patients may feel intoxicated during the administration of —
    Answer:
    Carmustine (BCNU)<\/li>\n<\/ol>\n\n\n\n

    Q: Patients are prophylactically medicated with anticonvulsants before receiving — and for 24
    hours after the last dose to prevent seizures
    Answer:
    Busulfan
    Q: True or False: Oxaliplatin should only be mixed with D5W
    Answer:
    True
    Q: Which drug should ALWAYS be given with Mesna?
    Answer:
    Ifosfamide
    Q: Pulmonary fibrosis is a late complication of patients who receive —
    Answer:
    Busulfan
    Q: The platinum alkylating agents include –, –, and —
    Answer:
    Cispiatin, Carboplatin, Oxaliplatin
    Q: Cisplatin (Platinol) is a — emetogenic drug
    Powered by https:\/\/learnexams.com\/search\/study?query=<\/a><\/p>\n\n\n\n